ERN1 and cancer: Our study extends these findings by demonstrating that the alteration of IRE1α–XBP1 signaling we identified may contribute to the dysregulation of ER chaperones and UPR components observed in cancers in part, and that necrosis may serve as a critical factor exacerbating UPR dysfunction in GBM.